Reoperation in recurrent high-grade gliomas: Literature review of prognostic factors and outcome

Alba A. Brandes, Francesca Vastola, Silvio Monfardini

Research output: Contribution to journalArticlepeer-review

Abstract

Two percent of cancer deaths are caused by malignant primary brain tumors, and most of these are high-grade gliomas. Despite the treatment given, malignant gliomas recur early. Mean survival is less than 12 months, and only 20% of patients survive for more than 2 years. This rapid course induces some physicians to resort to all the therapeutic options available and, at recurrence, to reevaluate the patient for a second intervention. Others consider reoperation to be an overtreatment. The debate is ongoing, and an answer likely will be found only through better identification of the prognostic factors that will identify patients who will benefit from reoperation.

Original languageEnglish
Pages (from-to)387-390
Number of pages4
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume22
Issue number4
DOIs
Publication statusPublished - Aug 1999

Keywords

  • Prognostic factors
  • Recurrent high-grade gliomas
  • Reoperation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Reoperation in recurrent high-grade gliomas: Literature review of prognostic factors and outcome'. Together they form a unique fingerprint.

Cite this